Aytu Biopharma AYTU
NASDAQ AYTU
$2.15 +0.06 (+2.87%)
As of: Oct 2, 2026 · 10:40 AM EDT

Aytu Biopharma (AYTU) Accumulated Expenses (2013 - 2026)

Updated

Aytu Biopharma (AYTU) posted Accumulated Expenses of $35.21 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 7.8% from $38.16 million a year earlier but up 2.7% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Accumulated Expenses (2013 - 2026) Analysis & Trends

Since fiscal Q4 2013, Aytu Biopharma has reported Accumulated Expenses for 43 quarters.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of -9.3% (FY2021 to FY2026).
  • In prior fiscal years, Aytu Biopharma's Accumulated Expenses was $38.16 million in FY2025 (+0.1%), $38.14 million in FY2024 (-18.5%), $46.8 million in FY2023 (+5.9%) and $44.19 million in FY2022 (-22.8%).
  • Quarterly Accumulated Expenses has run from a low of $33.72 million in fiscal Q1 2025 to a high of $54.38 million in fiscal Q1 2022 over five years.
  • On a year-over-year basis, Accumulated Expenses increased in three of the last eight quarters, with an average decline of 5.8%.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was fiscal Q1 2022, with growth of 525.6%; the weakest was fiscal Q1 2023, with a decline of 23.8%.
  • According to Business Quant data, Accumulated Expenses for the three prior fiscal quarters was $34.27 million (Q3 2026), $40.16 million (Q2 2026) and $36.7 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aytu Biopharma 23.25 Mn -92.42 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.21 Mn
Mar 31, 2026 34.27 Mn
Dec 31, 2025 40.16 Mn
Sep 30, 2025 36.70 Mn
Jun 30, 2025 38.16 Mn
Mar 31, 2025 41.73 Mn
Dec 31, 2024 39.37 Mn
Sep 30, 2024 33.72 Mn
Jun 30, 2024 38.14 Mn
Mar 31, 2024 44.09 Mn
Dec 31, 2023 43.41 Mn
Sep 30, 2023 40.73 Mn
Jun 30, 2023 46.80 Mn
Mar 31, 2023 49.59 Mn
Dec 31, 2022 41.22 Mn
Sep 30, 2022 41.43 Mn
Jun 30, 2022 44.19 Mn
Mar 31, 2022 53.47 Mn
Dec 31, 2021 50.69 Mn
Sep 30, 2021 54.38 Mn
API Access

Aytu Biopharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEY